Stocks
Amylyx Pharmaceuticals, Inc.AMLX
NASDAQHealthcareBiotechnology$13.99-2.71%
Focused on developing treatments for neurodegenerative diseases, this biopharmaceutical company gained investor attention with its lead candidate for ALS. Its market position hinges on clinical trial outcomes and regulatory approvals in competitive neurology markets.
Market Cap: $1.2B52W Range: $3.11 – $17.49
Congressional Interest in Amylyx Pharmaceuticals, Inc. (AMLX)
1 member of Congress has disclosed 1 trade in Amylyx Pharmaceuticals, Inc. (AMLX), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading AMLX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-10-12 | Christopher L. Jacobs | buy | $1K – $15K |